HGSI Stock Human Genome Science July 20, 2009 No Comments
HGSI stock, Human Genome Sciences, is trading very high today because of recent news in the development of a new drug for lupus. The company, HGSI, Human Genome Sciences, announced earlier today that it’s experimental drug for lupus has been tested successfully with positive results in a late stage clinical test. HGSI, is introducing one [...]